I dyremodeller, hvor der anvendes Bcr- Abl- positive tumorceller, har stoffet som enkeltstof in vivo antitumoraktivitet.
In vivo the compound shows anti-tumour activity as a single agent in animal models using Bcr-Abl positive tumour cells.